Acute regulation of plasma leptin by isoprenaline in lean and obese fasted subjects

Diabetes, Obesity and Metabolism

Volumn 8, Issue 4, 2006, Pages 412-418

  Baynes, K C R ^a   Nicholas, M D ^a   Shojaee Moradie, F ^a   Umpleby, A M ^a   Giannoulis, Manthos G ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b General Clinic of Thessaloniki   (Greece)

Author keywords

Isoprenaline; Leptin; Lipolysis; Obesity

Indexed keywords

GLYCEROL; ISOPRENALINE; LEPTIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DRUG DOSE REGIMEN; DRUG INFUSION; ELECTROCARDIOGRAPHY; GLYCEROL BLOOD LEVEL; HEADACHE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPERLEPTINEMIA; HYPOTHESIS; LEAN BODY WEIGHT; LIPOLYSIS; MALE; NORMAL HUMAN; OBESITY; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; STUDENT T TEST; TACHYCARDIA;

EID: 33748474965     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00517.x     Document Type: Article

References (36)

1. Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 1996; 81: 4162-4165.
2. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996; 81: 3419-3423.
3. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
4. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
5. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
6. Pelleymounter MA, Cullen MJ, Baker MB et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-546.
7. Carulli L, Ferrari S, Bertolini M, Tagliafico E, Del Rio G. Regulation of ob gene expression: Evidence for epinephrine-induced suppression in human obesity. J Clin Endocrinol Metab 1999; 84: 3309-3312.
8. Donahoo WT, Jensen DR, Yost TJ, Eckel RH. Isoproterenol and somatostatin decrease plasma leptin in humans: A novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 1997; 82: 4139-4143.
9. Kosaki A, Yamada K, Kuzuya H. Reduced expression of the leptin gene (Ob) by catecholamine through a Gs protein-coupled pathway in 3T3-L1 adipocytes. Diabetes 1996; 45: 1744-1749.
10. Pinkney HJ, Coppack SW, Mohamed-Ali V. Effect of isoprenaline on plasma leptin and lipolysis in humans. Clin Endocrinol (Oxf) 1998; 48: 407-411.
11. 3 -adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 1996; 137: 4054-4057.
12. 3 -adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 1996; 45: 909-914.
13. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 1994; 35: 177-193.
14. Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993; 34: 1057-1091.
15. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83: 1168-1173.
16. Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H, Arner P. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest 1994; 93: 2590-2599.
17. Arner P, Engfeldt P, Nowak J. In vivo observations on the lipolytic effect of noradrenaline during therapeutic fasting. J Clin Endocrinol Metab 1981; 53: 1207-1212.
18. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 1996; 44: 1467-1470.
19. Wabitsch M, Jensen PB, Blum WF et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996; 45: 1435-1438.
20. Clapham JC, Smith SA, Moore GBT et al. Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans. Int J Obes Relat Metab Disord 1997; 21: 179-183.
21. Kolaczynski JW, Nyce MR, Considine RV et al. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
22. Sönksen PH. Double antibody technique for the simultaneous assay of insulin and growth hormone. In: Antoniades HN ed. Hormones in Human Blood: Detection and Assay. Cambridge, MA: Harvard University Press, 1976; p. 176-199.
23. Slieker LJ, Sloop KW, Surface PL et al. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996; 271: 5301-5304.
24. Snitker S, Hellmer J, Boschmann M et al. In situ lipolytic responses to isoproterenol and physiological stressors are similar in obese Pima Indians and Caucasians. J Clin Endocrinol Metab 1998; 83: 4054-4058.
25. Fried SK, Ricci MR, Russell CD, Laferrère B. Regulation of leptin production in humans. J Nutr 2000; 130: 3127S-3131S.
26. Gong DW, Bi S, Pratley RE, Weintraub BD. Genomic structure and promoter analysis of the human obese gene. J Biol Chem 1996; 271: 3971-3974.
27. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 1996; 334: 292-295.
28. Pratley RE, Nicolson M, Bogardus C, Ravussin E. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin resistant Pima Indians. J Clin Endocrinol Metab 1996; 81: 4418-4421.
29. Ryan AS, Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: Its relationships with body fat, visceral adiposity and age in women. J Clin Endocrinol Metab 1996; 81: 4433-4438.
30. Cammisotto PG, Gelinas Y, Deshaies Y, Bukowiecki LJ. Regulation of leptin secretion from white adipocytes by free fatty acids. Am J Physiol Endocrinol Metab 2003; 285: E521-E526.
31. Wang-Fisher Y-L, Han J, Guo W. Acipimox stimulates leptin production from isolated rat adipocytes. J Endocrinol 2003; 174: 267-272.
32. Fisher JS, Hickner RC, Racette SB, Binder EF, Landt M, Kohrt WM. Leptin response to insulin in humans is related to the lipolytic state of abdominal subcutaneous fat. J Clin Endocrinol Metab 1999; 84: 3726-3731.
33. Bougneres P, Le Stunff C, Pecqueur C, Pinglier E, Adnot P, Ricquier D. In vivo resistance of lipolysis to epinephrine. J Clin Invest 1997; 99: 2568-2573.
34. Jensen MD, Haymond MW, Gerich JE, Cryer PE, Miles JM. Lipolysis during fasting: Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest 1987; 79: 207-213.
35. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat b3 adrenoreceptors in obesity. J Clin Invest 1995; 95: 1109-1116.
36. Montague CT, Prins JP, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression. Diabetes 1997; 46: 342-347.